Rare Diseases’ therapies integration in diagnostic support tools through the Treatabolome platform

21 October 2021

Presented by :

– Gisele Bonne, Sorbonne University – INSERM – Institut of Myology, Paris, France
– Carles Hernandez-Ferrer, CNAG -CRG, Barcelona, Spain
– Katja Lohmann, Institute of Neurogenetics, Lübeck University, Lübeck, Germany

Treatabolome is a database that will be publically available on the internet to facilitate the identification of existing treatments for rare diseases. Gisele Bonne will introduce the Treatabolome concept. Carles Hernandez-Ferrer will talk about the development and implementation of the Treatabolome platform and Katja Lohmann will emphasize the synergies between the MSDgene and Treatabolome platforms.

Further details

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern